Net Cash Provided by (Used in) Operating Activities |
-23.6K |
USD |
-81.7% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
23.6K |
USD |
+80.2% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
1B |
shares |
0% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares, Issued |
4.5M |
shares |
-0.2% |
Q1 2025 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
99 |
USD |
+254% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
76 |
USD |
-29% |
Q1 2025 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2025 |
Q1 2025 |
Preferred Stock, Shares Issued |
1.94M |
shares |
|
Q1 2025 |
Q1 2025 |
Preferred Stock, Shares Authorized |
10M |
shares |
|
Q1 2025 |
Q1 2025 |
Additional Paid in Capital |
536K |
USD |
+0.48% |
Q1 2025 |
Q1 2025 |
Preferred Stock, Shares Outstanding |
1.94M |
shares |
|
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
219K |
USD |
+7.35% |
Q1 2025 |
Q1 2025 |
Interest Expense |
8.64K |
USD |
+11.8% |
Q1 2025 |
Q1 2025 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q1 2025 |
Q1 2025 |